APA (7th ed.) Citation

M, Y., D, Y., X, C., Y, Y., B, Z., X, J., . . . N, L. (2026). Metabolic reprogramming in cancer: Dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities. Molecular biomedicine, 7(1), . https://doi.org/10.1186/s43556-026-00427-2

Chicago Style (17th ed.) Citation

M, Yu, Yang D, Chen X, Yang Y, Zhang B, Jiang X, Xing L, Sun Y, and Li N. "Metabolic Reprogramming in Cancer: Dysregulation of Glucose, Lipid, and Amino Acid Pathways and Therapeutic Opportunities." Molecular Biomedicine 7, no. 1 (2026). https://doi.org/10.1186/s43556-026-00427-2.

MLA (9th ed.) Citation

M, Yu, et al. "Metabolic Reprogramming in Cancer: Dysregulation of Glucose, Lipid, and Amino Acid Pathways and Therapeutic Opportunities." Molecular Biomedicine, vol. 7, no. 1, 2026, https://doi.org/10.1186/s43556-026-00427-2.